Professor Graham Scotland

In this section
Professor Graham Scotland
Professor Graham Scotland
Professor Graham Scotland

Interim Director of HERU

About

Biography

Graham is a Professor and leads the Assessment of Technologies theme in HERU. He joined HERU in 2004 and held a joint appointment between HERU and the Health Services Research Unit (HSRU) from 2012 to 2022. His current research interests span both model- and trial-based economic evaluation, with particular emphasis on the use decision analytic modelling alongside randomised controlled trials to maximise their value for informing health care decision making. Graham graduated from the University of Edinburgh in 1998 with BSc (Hons) in pharmacology, and following this undertook an MSc in Health Services and Public Health Research at the University of Aberdeen. After completing his MSc he worked at the Dugald Baird Centre for Research in Women's Health, University of Aberdeen, where he undertook research into economic aspects of maternal healthcare delivery in developing countries. Since his appointment in HERU he has gained over 19 years’ experience working in the area of health technology assessment. Graham also has an in interest in how the broader measures of value can incorporated in health technology assessment, and in 2012 completed a part-time PhD on methods for incorporating broader measures of value into economic evaluation in the area of reproductive healthcare.

Publications

Page 3 of 9 Results 21 to 30 of 86

  • Assessing couples' preferences for fresh or frozen embryo transfer: a discrete choice experiment

    Abdulrahim, B., Scotland, G., Bhattacharya, S., Maheshwari, A.
    Human reproduction (Oxford, England), vol. 36, no. 11, pp. 2891-2903
    Contributions to Journals: Articles
  • Palforzia for treating peanut allergy

    Cruickshank, M., Boyers, D., Scott, N., Robertson, C., Manson, P., Lumsden, C., Scotland, G., Brazzelli, M.
    London: Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 125 pages
    Books and Reports: Commissioned Reports
  • Venetoclax with a hypomethylating agent or low dose cytarabine for untreated acute myeloid leukaemia unsuitable for intensive chemotherapy

    Cruickshank, M., Kennedy, C., Aucott, L., Booth, C., Imamura, M., Vadiveloo, T., Manson, P., Preston, G., Scotland, G., Brazzelli, M.
    London: National Institute for Health and Care Excellence (NICE)
    Books and Reports: Commissioned Reports
  • Berotralstat for preventing acute attacks of hereditary angioedema

    Robertson, C., Booth, C., Ayansina, D., Hernández, R. A., Manson, P., Herriot, R., Brazzelli, M., Scotland, G.
    London: National Institute for Health and Care Excellence (NICE)
    Books and Reports: Commissioned Reports
  • Cost-effectiveness and value of information analysis of multiple frequency bioimpedance devices for fluid management in people with chronic kidney disease having dialysis

    Jacobsen, E., Cruickshank, M., Cooper, D., Marks, A., Brazzelli, M., Scotland, G.
    Cost Effectiveness and Resource Allocation, vol. 19, 24
    Contributions to Journals: Articles
  • The Help for Hay Fever community pharmacy-based pilot randomised controlled trial for intermittent allergic rhinitis

    Smith, S., Porteous, T., Bond, C., Francis, J., Lee, A. J., Lowrie, R., Scotland, G., Sheikh, A., Thomas, M., Wyke, S., Smith, L.
    npj Primary Care Respiratory Medicine, vol. 30, pp. 23
    Contributions to Journals: Articles
  • Glyceryl trinitrate to reduce the need for manual removal of retained placenta following vaginal delivery: The GOT-IT RCT

    Denison, F. C., Carruthers, K. F., Hudson, J., McPherson, G., Scotland, G., Brook-Smith, S., Clarkson, C., Peace, M., Brewin, J., Chua, G. N., Hallowell, N., Norman, J. E., Lawton, J., Norrie, J.
    Health Technology Assessment, vol. 23, no. 70, pp. 1-72
    Contributions to Journals: Articles
  • Atezolizumab monotherapy for untreated advanced non-small-cell lung cancer

    Aucott, L., Robertson, C., Walker, A., Manson, P., Price, G., Scotland, G., Brazzelli, M.
    Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
    Books and Reports: Commissioned Reports
  • Darolutamide with androgen deprivation therapy for treating non-metastatic hormone-relapsed prostate cancer

    Scotland, G., Kennedy, C., Imamura, M., Cooper, D., Robertson, C., Booth, C., Urquhart, G., Brazzelli, M.
    National Institute for Health and Care Excellence (NICE)
    Books and Reports: Commissioned Reports
  • Enzalutamide with ADT for treating metastatic hormone-sensitive prostate cancer

    Kopasker, D., Robertson, C., Aucott, L., Vadiveloo, T., Imamura, M., Manson, P., Walker, A., Urquhart, G., Brazzelli, M., Scotland, G., Aberdeen HTA Group
    National Institute for Health and Care Excellence (NICE)
    Books and Reports: Commissioned Reports
Show 10 | 25 | 50 | 100 results per page

Refine

Books and Reports

Contributions to Conferences

Contributions to Journals